NCT05375045

Brief Summary

Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
868

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Mar 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Mar 2022Feb 2028

First Submitted

Initial submission to the registry

March 3, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

March 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 16, 2022

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

May 16, 2022

Status Verified

May 1, 2022

Enrollment Period

5.3 years

First QC Date

March 3, 2022

Last Update Submit

May 10, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The success rate of tissue integration of the implant

    Integration of the implant 5 years after implantation

    5 years after implantation

Secondary Outcomes (7)

  • assessment of the quality of life of patients following the recovery of full dentition with the GOHAI score (General Oral Health Assessment Index)

    5 years after implantation

  • Complication rate taking into account pain, local tenderness, infection, mobility of the implant, fracture

    5 years after implantation

  • measuring chewing function after prosthesis placement

    5 years after implantation

  • Rate of inflammation (visual)

    5 years after implantation

  • Assessment of the evolution of the péri-implant tissues

    5 years after implantation

  • +2 more secondary outcomes

Study Arms (2)

prospective

A prospective cohort will be recruited into the study to meet the secondary objective of improving quality of life. In fact, to measure the improvement in quality of life, a questionnaire must be completed by the patient before the implant is placed. Answers to this questionnaire preoperatively cannot be collected for patients recruited retrospectively.

Device: dental implantation

retrospective

Patients who received one or more EUROTEKNIKA implants before 2017 may be included in the study for the retrospective cohort

Interventions

an implant is surgically inserted into the maxilla or mandible, and then an abutment is connected to this implant to support the dental prosthesis.

prospective

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who received one or more EUROTEKNIKA implants before 2017 may be included in the study for the retrospective cohort for Naturactis, Naturall+, Aesthetica+2, ORIGIN, iBone E, iBone S and iBone G implants. These patients will be included consecutively in chronological order to avoid selection bias. A prospective cohort will also be recruited in the study, in order to meet the secondary objective concerning the improvement of the quality of life. In fact, to measure the improvement in quality of life, a questionnaire must be completed by the patient before the implant is placed. Answers to this questionnaire preoperatively cannot be collected for patients recruited retrospectively.

You may qualify if:

  • Patient aged 18 or over
  • Patient who has completed bone growth
  • Patient informed and agreeing to participate in the study
  • Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort)
  • Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort)
  • Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort)
  • Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort)

You may not qualify if:

  • Pregnant or breastfeeding women (for the prospective cohort)
  • Patient with bone disease in the cervico-facial region
  • Patient refusing to participate in the study
  • Patient with at least one contraindication to implantation (for the prospective cohort)
  • Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort)
  • Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort)
  • Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort)
  • Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Clermont Ferrand

Clermont-Ferrand, 63003, France

RECRUITING

MeSH Terms

Conditions

Mouth, Edentulous

Interventions

Dental Implantation

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesTooth Diseases

Intervention Hierarchy (Ancestors)

Oral Surgical Procedures, PreprostheticOral Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationDentistryProsthodontics

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2022

First Posted

May 16, 2022

Study Start

March 25, 2022

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

May 16, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations